Phosphorus Supplement 1.8% w/v Solution for Injection

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Phosphorus

Available from:

Alfasan Nederland B.V.

ATC code:

QA12CX

INN (International Name):

Phosphorus

Pharmaceutical form:

Solution for injection

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Cattle

Therapeutic area:

Mineral

Authorization status:

Authorized

Authorization date:

1995-07-06

Summary of Product characteristics

Revised: August 2021
AN: 00888/2021
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Phosphorus Supplement 1.8 % w/v Solution for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE
Qualitative composition
Calcium hypophosphite
(equivalent to Phosphorus 1.8 % w/v)
EXCIPIENTS
For a full list of excipients, see
section 6.1.
Quantitative composition
4.84 % w/v
3.
PHARMACEUTICAL FORM
Solution for injection.
A clear, colourless, sterile, aqueous solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of acute hypophosphataemia in cattle. Also as an aid
in
raising blood calcium levels where a deficiency may be expected.
4.3
CONTRAINDICATIONS
Do not use in hyperphosphataemic animals.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Preferably warm the solution to body temperature before use.
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
None known.
Revised: August 2021
AN: 00888/2021
Page 2 of 4
ii.
Special precautions for the person administering the veterinary
medicinal
product to animals
IF CONTACT WITH THE SKIN OCCURS, THE AREA SHOULD BE WASHED WITH SOAP
AND WATER. IF IRRITATION OCCURS, SEEK MEDICAL ADVICE.
If contact with eyes occurs, wash eyes with plenty of clean water. If
irritation
occurs, seek medical advice.
Following oral ingestion, the mouth should be washed out and plenty of
water
consumed. Seek medical advice if irritation occurs.
If accidental self-injection occurs or if signs of adverse effects are
seen, seek
medical attention immediately, showing the product label to a doctor.
Wash hands after use.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not contraindicated.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9
AMOUNT(S) TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Cattle: up to 400 ml by intravenous injection (approximately 1
ml/kg/day).
4.